Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.
You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.
After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.
digitally watermarked, no DRM
The eBook version of this title will be available soon
Connective Tissue Diseases (CTDs) are often still poorly understood and always difficult to manage, however, they are now starting to become increasingly recognised. A CTD is any disease that has the connective tissues of the body as a primary target of pathology, and since these types of tissue include any kind of biological tissue with an extensive extra-cellular matrix that supports, binds together or protects organs, CTDs can prove constantly problematic. Many connective tissue diseases feature abnormal immune system activity, with inflammation in tissues as a result of an immune system that is directed against one's own body tissues (autoimmunity). Connective tissue diseases can be sometimes caused by environmental factors, and can also have strong or weak inheritance risks.
CTDs can be very severe in individuals of Afro-Caribbean or South-East Asian origin, therefore there is a very large market opening up for the management of these diseases in China, Singapore, Malaysia, and the Indian sub-continent. There is currently no compact handbook available on the diagnosis and subsequent management of these diseases, and so given the prevalence of CTDs in pockets around the whole world, there is potentially an extensive global market.
Rather than focusing on rheumatogists already familiar with CTD, the book would be aimed more at the general clinician and practitioner, equipping them to handle the requirements of the unique treatment, as well as rheumatologist trainees and nurses wishing to specialise.